Enteric fever, typhoid, paratyphoid, first-in-human
Typhoid fever, Typhoid conjugate vaccine, Vi-tetanus toxoid conjugate, Vaccine effectiveness, Waning protection, Long-term effectiveness, Nepal
Vi-CRM197, Typhoid, Immunogenicity, Heterologous booster, Conjugate, Nepal, Vaccine
Typhoid Conjugate vaccine, Typhoid Fever, Immunogenicity, Vi-TCV
Typhoid conjugate vaccine, Nepal, Immunogenicity, Antibody persistence, Seroconversion, Children